Premium Information is available for this item - Upgrade for $1 a day
6505-01-308-6192
Usp Gentamicin Sulfate Injection
6505013086192 013086192 30-818-OK-02 3401-02 ADD-VANTAGE NDC00074-3401-01
INC: 37890 Gentamicin Sulfate Injection
January 2023
5
Marketplace 6505-01-308-6192
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-308-6192 5+ Documents (More...)
United States (US) 4. 6505-01-308-6192 Marketplace Restrictions Approved Sources Datasheet Management
RQST NE Updated Every Day 6505-01-308-6192 RQST Updated Every Day 6505-01-308-6192 RQST NE Related Documents
NDC00074-3401-02 Managed by United States NSN Created on 28 Sep 1991 Data Last Changed January 2023
fsc-6505/us 6505-01-346-2062 Usp Gentamicin Sulfate Injection 013462062 F91G489ADD-VANTAGENDC00074-3401-02
Upgrade 6505-01-285-5746Usp Cefotaxime Sodium6505012855746 012855746 NDC00039-0023-25 CLAFORAN IN ADD VANTAGE
VIALS Created on 31 Oct 1989 Data CLAFORAN IN ADD-VANTAGE https//www.nsnlookup.com /fsg-65/fsc-6505/
65/fsc-6505/us 6505-01-285-5746 Usp Cefotaxime Sodium 6505012855746 NDC00039-0023-25CLAFORAN IN ADD VANTAGE
Upgrade 6505-01-285-5746Usp Cefotaxime Sodium6505012855746 012855746NDC00039-0023-25CLAFORAN IN ADD VANTAGE
Created on 31 Oct United States NSN Created on 31 Oct United States NSN Created on 31 Oct CLAFORAN IN ADD-VANTAGE
VIALS NDC00039-0024-50 Managed by United States NSN Created on 10 Dec 1989 Data CLAFORAN IN ADD-VANTAGE
Restrictions 6505-01-308-6192
6505-01-308-6192 is a Usp Gentamicin Sulfate Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-308-6192
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-308-6192
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-308-6192
- Part Number
- Manufacturer
- Status
- NDC00074-3401-01
- Manufacturer
- 70048 - Abbott Laboratories (Active)
- Primary Buy
- Primary Buy
- 30-818-OK-02
- 70048 - Abbott Laboratories (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
- 3401-02
- 70048 - Abbott Laboratories (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
- ADD-VANTAGE
- 70048 - Abbott Laboratories (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-308-6192
- Characteristic
- Specifications
- FIIG
- Specifications
- A45100
- Active Medicament Medicinal Strength [AKJA]
- 10.000 Milligrams Gentamicin Sulfate Equivalent
- Administration [CSGS]
- Intramuscular
- Primary Container Type [CQCT]
- Vial
- Primary Container Content Quantity [CRLK]
- 2.000 Milliliters
- Total Primary Container Quantity [CSCW]
- 50
Similar Supply Items to 6505-01-308-6192
Freight Information 6505-01-308-6192
6505-01-308-6192 has freight characteristics.. 6505-01-308-6192 has a variance between NMFC and UFC when transported by rail and the description should be consulted.